Cohance Lifesciences Approves Employee Stock Option Plans, Allots 30,190 Shares under ESOP 2023
Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) announced the approval of its nomination and remuneration committee regarding its employee stock option plans. The committee approved key details related to both the new Cohance Lifesciences Limited Employee Stock Option Plan, 2026 (ESOP 2026), and actions concerning the existing Suven Pharmaceuticals Limited Employee Stock Option Plan, 2023 (ESOP 2023).Key decisions made by the Nomination and Remuneration Committee on July 23, 2026, included granting options to eligible employees under both schemes. Up to 19,748,317 stock options were approved for grant under the ESOP 2026. Additionally, 174,843 stock options were granted to eligible employees under the ESOP 2023.
In an update related to ESOP 2023, the Committee approved the cancellation of 1,87,703 grants out of a previously announced grant of 1,98,711 stock options. These cancelled stock options are available for future allotment under the terms of ESOP 2023.
The company also confirmed the allotment of 30,190 equity shares to those who exercised their options vested under the ESOP 2023. The allotted shares have a face value of INR 1 each and are fully paid up.
ESOP 2026 Grant Details
Details concerning the new ESOP 2026 include the total pool size, pricing parameters, and vesting conditions.| Particulars | ESOP 2026 Details |
|---|---|
| Total Options Covered | Up to 19,748,317 options |
| Scheme Status | In accordance with SEBI (SBEB) Regulations, 2021 |
| Vesting Period | Minimum 1 year and Maximum 8 years from the grant date |
| Exercise Period | Up to 3 years from the date of vesting |
ESOP 2023 Allotment and Share Structure Update
The allotment under ESOP 2023 occurred on July 23, 2026. The shares issued were allotted at an exercise price of INR 268.18. This allotment increased the total outstanding equity shares in the company.| Parameter | Details |
|---|---|
| Options Granted (ESOP 2023) | Up to 174,843 |
| Allotted Shares | 30,190 |
| Exercise Price per Share | INR 268.18 |
| Premium per Share | INR 267.18 |
| Total Issued Shares Post-Allotment | 38,25,97,330 |
The ESOP 2023 is governed by significant terms that detail the options available to employees and can be accessed on the company’s website.
COHANCE Stock Price Movement
Today, shares of Cohance Lifesciences Limited tumbled, shedding 3.86% and settling at ₹422.10 after trading closed today. The stock recorded a total traded volume of 613,940 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.